October 2, 2007 -
Upstream Biosciences Inc. (
OTCBB: UPBS) announced that its Chief Executive Officer, Joel L. Bellenson, will unveil Upstream's promising new drug candidates in a keynote address to the International Scientific Council for
Trypanosomiasis Research and Control (ISCTRC) conference being held in Angola from October 1 to 5, 2007...
Trypanosomiasis is the medical term for the disease known as
African sleeping sickness.... Upstream recently acquired access to innovative drug candidates designed to treat tropical parasitic diseases. In laboratory studies in vitro, these compounds have demonstrated human and veterinary potential against several major tropical parasitic diseases, including
trypanosomiasis...
Upstream Biosciences' Press Release -
